Payer

Step Therapy

A payer requirement that less expensive drug or service options be tried before more expensive alternatives are covered.

1 min read · Last reviewed May 23, 2026

At a glance

Category
Payer
Primary sources
1
Workspace handoff
denial workbench

Where this comes up

Front-office and billing both hit this term — eligibility before the visit, prior auth before the procedure, contract terms during fee-schedule negotiation, and credentialing whenever a new provider joins or a payer roster lapses. Misses here become denials downstream.

Full definition

What it is in practice

Step therapy is permitted in Medicare Part D and increasingly in Part B (under MA plans, per CMS guidance). Exceptions and appeals are statutory.

How it shows up in your practice

Document failed therapies before stepping up. Anticipate step-therapy denials on high-cost drugs and prepare appeal templates.

Sources

Take it into the workspace

Defend step-therapy denials in the Denial Workbench

Open denial workbench
Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

This glossary entry is a research aid for billing and compliance staff. It does not provide legal, medical, or financial advice and does not replace counsel. References cited link to primary sources at HHS, OCR, CMS, eCFR, NIST, and the relevant payer or industry body.